Search Results - "Nurmohamed, Michael"

Cardiovascular comorbidity in rheumatic diseases by Nurmohamed, Michael T., Heslinga, Maaike, Kitas, George D.

“…Key Points Patients with inflammatory joint diseases (IJDs) have an increased burden of cardiovascular disease compared with the general population…”
Get full text

Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner by Krieckaert, Charlotte L, Nurmohamed, Michael T, Wolbink, Gerrit Jan

Get more information

Is atherosclerosis an autoimmune disease? by Matsuura, Eiji, Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Turiel, Maurizio, Lopez, Luis R, Nurmohamed, Michael T

“…Immunologic research into pathogenic mechanisms operating in autoimmune-mediated atherosclerosis initially focused on adaptive immunity. Current interest is…”
Get full text

Cardiovascular effects of approved drugs for rheumatoid arthritis by Atzeni, Fabiola, Rodríguez-Carrio, Javier, Popa, Călin D., Nurmohamed, Michael T., Szűcs, Gabriella, Szekanecz, Zoltán

“…The risk of cardiovascular disease is increased in patients with rheumatoid arthritis compared with the general population owing to the influence of…”
Get full text

Key findings towards optimising adalimumab treatment: the concentration-effect curve by Pouw, Mieke F, Krieckaert, Charlotte L, Nurmohamed, Michael T, van der Kleij, Desiree, Aarden, Lucien, Rispens, Theo, Wolbink, Gertjan

“…To determine a concentration-effect curve of adalimumab in rheumatoid arthritis (RA) patients taking into account the effect of methotrexate (MTX) on…”
Get more information

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022 by Dijkshoorn, Bas, Raadsen, Reinder, Nurmohamed, Michael T

“…The risk for developing cardiovascular diseases (CVD) in rheumatoid arthritis (RA) patients is 1.5 times higher compared to the general population. This risk…”
Get full text

Can personalized use of NSAIDs be a reality in the clinic? by Nurmohamed, Michael T.

“…The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis…”
Get full text

Cardiovascular risk in rheumatoid arthritis by Nurmohamed, Michael T

“…Abstract The increased mortality in rheumatoid arthritis (RA) is mainly due to (atherosclerotic) cardiovascular disease. The cardiovascular morbidity is also…”
Get full text

Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity by Heslinga, Maaike, Lambert, Gilles, Thédrez, Aurélie, Kastelein, John, Nurmohamed, Michael T

Get full text

Cardiovascular disease in inflammatory rheumatic diseases by Castañeda, Santos, Nurmohamed, Michael T, González-Gay, Miguel A

“…Abstract Chronic inflammatory rheumatic diseases (IRD), including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, are prevalent…”
Get full text

Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry" by van Vollenhoven, Ronald F, Tas, Sander W, Nurmohamed, Michael T

Get more information

A neutrophil signature is strongly associated with increased cardiovascular risk in gout by Vedder, Daisy, Gerritsen, Martijn, Nurmohamed, Michael T, van Vollenhoven, Ronald F, Lood, Christian

“…Abstract Objective To investigate the association between neutrophil activation and cardiovascular risk in gout patients. We hypothesize that neutrophil…”
Get full text

Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study by van Sijl, Alper M, Boers, Maarten, Voskuyl, Alexandre E, Nurmohamed, Michael T

“…To evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. Retrospective analysis of exposure to…”
Get full text

Editorial: Treat to Target in Rheumatoid Arthritis: Good for the Joints as Well as the Heart? by Nurmohamed, Michael T.

Get full text

Does Adding Single‐Nucleotide Polymorphisms to Risk Algorithms Improve Cardiovascular Disease Risk Prediction in Rheumatoid Arthritis? An Internal and External Validation of a Clinical Risk Score by Agca, Rabia, Popa, Calin D., Heymans, Martijn W., Crusius, Bart, Voskuyl, Alexandre E., Nurmohamed, Michael T.

“…Objective Current risk algorithms do not accurately predict cardiovascular disease (CVD) risk in rheumatoid arthritis (RA). An area of interest is that of…”
Get full text

A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis by Meeberg, Maartje M., Hebing, Renske C. F., Nurmohamed, Michael T., Fidder, Herma H., Heymans, Martijn W., Bouma, Gerd, Bruin‐Weller, Marjolein S., Tekstra, Janneke, Bemt, Bart, Jonge, Robert, Bulatović Ćalasan, Maja

“…Aims In immune‐mediated inflammatory diseases (IMIDs), early symptom control is a key therapeutic goal. Methotrexate (MTX) is the first‐line treatment across…”
Get full text

Cardiovascular risk in persons at risk of developing rheumatoid arthritis by van Boheemen, Laurette, van Beers-Tas, Marian H, Kroese, Johanna M, van de Stadt, Lotte A, van Schaardenburg, Dirkjan, Nurmohamed, Michael T

“…Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this…”
Get full text

Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years by Visman, Ingrid M., Atiqi, Sadaf, Boers, Maarten, Twisk, Jos W.R., Nurmohamed, Michael T.

“…Objective To study changes in retention of first biologic disease-modifying antirheumatic drug (DMARD) therapy over a period of 15 years in an inception cohort…”
Get full text

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up by Bartelds, Geertje M, Krieckaert, Charlotte L. M, Nurmohamed, Michael T, van Schouwenburg, Pauline A, Lems, Willem F, Twisk, Jos W. R, Dijkmans, Ben A. C, Aarden, Lucien, Wolbink, Gerrit Jan

“…CONTEXT Short-term data on the immunogenicity of monoclonal antibodies showed associations between the development of antidrug antibodies and diminished serum…”
Get full text

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review by Jamnitski, Anna, Symmons, Deborah, Peters, Mike J L, Sattar, Naveed, McInnes, Iain, McIinnes, Iain, Nurmohamed, Michael T

“…Data regarding cardiovascular comorbidity and cardiovascular risk factors in patients with psoriatic arthritis (PsA) are limited. To evaluate the…”
Get more information